Vol 75, No 3 | The Journal of Clinical Psychiatry

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

J Clin Psychiatry 2014;75(3):274-275

Anissa Abi-Dargham, MD; Jonathan M. Meyer, MD

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

J Clin Psychiatry 2014;75(3):e184-e190

W. Wolfgang Fleischhacker, MD; John M. Kane, MD; Jamie Geier, PhD; Onur Karayal, MD, MPH; Sheela Kolluri, PhD; Sybil M. Eng, PhD; Robert F. Reynolds, ScD; Brian L. Strom, MD, MPH

Original Research

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

J Clin Psychiatry 2014;75(3):e191-e197

Lucas Giner, MD, PhD; Isabelle Jaussent, PhD; Emilie Olié, MD; Séverine Béziat, MSc; Sebastien Guillaume, MD, PhD; Enrique Baca-García, MD, PhD; Jorge Lopez-Castroman, MD, PhD; Philippe Courtet, MD, PhD

Original Research

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

J Clin Psychiatry 2014;75(3):222-230

Quang A. Le, PharmD, PhD; Jason N. Doctor, PhD; Lori A. Zoellner, PhD; Norah C. Feeny, PhD

Original Research

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

J Clin Psychiatry 2014;75(3):231-237

Nicolas Hoertel, MD; Bruno Falissard, MD, PhD; Keith Humphreys, PhD; Philip Gorwood, MD, PhD; Anne-Sophie Seigneurie, MD; Frédéric Limosin, MD, PhD

Original Research

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

J Clin Psychiatry 2014;75(3):247-253

Mark Olfson, MD, MPH; Kurt Kroenke, MD; Shuai Wang, PhD; Carlos Blanco, MD, PhD

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

J Clin Psychiatry 2014;75(3):e198-e200

Chittaranjan Andrade, MD

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

J Clin Psychiatry 2014;75(3):e201

Scott Temple, PhD

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

J Clin Psychiatry 2014;75(3):205-214

Silvana Borges, MD; Yeh-Fong Chen, PhD; Thomas P. Laughren, MD; Robert Temple, MD; Hiren D. Patel, PharmD; Paul A. David, RPh; Mitchell Mathis, MD; Ellis Unger, MD; Peiling Yang, PhD; Ni A. Khin, MD

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

J Clin Psychiatry 2014;75(3):e05

Larry Culpepper, MD, MPH

Educational Activity

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

J Clin Psychiatry 2014;75(3):e06

William G. Ondo, MD

Educational Activity

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

J Clin Psychiatry 2014;75(3):e07

Charles F. Brady, PhD, ABPP

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

J Clin Psychiatry 2014;75(3):254-263

Christian Simhandl, MD, PhD; Barbara König, PhD; Benedikt L. Amann, MD, PhD

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

J Clin Psychiatry 2014;75(3):285-287

Swapnil Gupta, MBBS, MD; John D. Cahill, MBBS; Mohini Ranganathan, MD; Christoph U. Correll, MD

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

J Clin Psychiatry 2014;75(3):288

Matthias W. Riepe, MD, Dipl-Phys

Letter to the Editor

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

J Clin Psychiatry 2014;75(3):289-290

Rex L. Cannon, PhD; H. E. Pigott, PhD; Tanju Surmeli, MD; Deborah R. Simkin, MD; Robert W. Thatcher, PhD; Werner Van den Bergh, MD; Gerald Gluck, PhD; Joel F. Lubar, PhD; Richard Davis, MS; Dale S. Foster, PhD; Jonathan Douglas, PhD; Atholl T. Malcolm, PhD; Donald Bars, PhD; Kirk Little, PsyD; Wes Center, PhD; Marvin Berman, PhD; Harold Russell, PhD; Barbara Hammer, PhD; J. Lucas Koberda, MD, PhD

Letter to the Editor

Dr van Dongen-Boomsma and Colleagues Reply

J Clin Psychiatry 2014;75(3):290

Martine van Dongen-Boomsma, MD; Madelon A. Vollebregt, MSc; Dorine Slaats-Willemse, PhD; Jan K. Buitelaar, MD, PhD

Letter to the Editor

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

J Clin Psychiatry 2014;75(3):290

Volume 75 • 2014 • 3

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

Dr van Dongen-Boomsma and Colleagues Reply

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

ELSEWHERE:

FOLLOW US:

Volume 75 • 2014 • 3

Commentary

Schizophrenia: The Role of Dopamine and Glutamate

Original Research

Completed and Attempted Suicides Among 18,154 Subjects With Schizophrenia Included in a Large Simple Trial

Violent and Serious Suicide Attempters: One Step Closer to Suicide?

Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial

Do Clinical Trials of Treatment of Alcohol Dependence Adequately Enroll Participants With Co-Occurring Independent Mood and Anxiety Disorders? An Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)

Trends in Office-Based Mental Health Care Provided by Psychiatrists and Primary Care Physicians

Clinical and Practical Psychopharmacology

Antidepressants and Testicular Cancer: Cause Versus Association

Book Review

Cognitive-Behavior Therapy for Children and Adolescents

Review Article

Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration

Educational Activity

Misdiagnosis of Bipolar Depression in Primary Care Practices

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Article

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

Letter to the Editor

High-Dose Cholinergic Therapy With Rivastigmine Patch Does Not Prolong QTc Time in Patients With Alzheimer's Disease

The Problem of Patient Heterogeneity and Lack of Proper Training in a Study of EEG Neurofeedback in Children

Dr van Dongen-Boomsma and Colleagues Reply

Correction: Continuation of Quetiapine Versus Switching to Placebo or Lithium for Maintenance Treatment of Bipolar I Disorder (Trial 144: A Randomized Controlled Study)

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles